Clinical Research Directory
Browse clinical research sites, groups, and studies.
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer
Sponsor: M.D. Anderson Cancer Center
Summary
This phase III trial studies how well hypofractionated radiation therapy works compared to the conventional one in treating patients with prostate cancer. Radiation therapy uses high energy beams to kill tumor cells and shrink tumors. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.
Official title: Post Operative External Beam Radiotherapy for Prostate Cancer: Randomized Trial Comparing Standard vs. Hypofractionated Radiation Therapy (PORT-HYFX)
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
186
Start Date
2019-05-30
Completion Date
2027-11-01
Last Updated
2025-11-12
Healthy Volunteers
No
Conditions
Interventions
Hypofractionated Radiation Therapy
Undergo hypofractionated radiation therapy
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
Radiation Therapy
Undergo conventional radiation therapy
Locations (3)
M D Anderson Cancer Center
Houston, Texas, United States
MD Anderson League City
League City, Texas, United States
MD Anderson in Sugar Land
Sugar Land, Texas, United States